The Philippines' battle against tuberculosis (TB) is a story of progress and challenges, as revealed in an interview with Rugaiya Calapis, a public health expert and chair of the DOH National Capital Region (NCR) South TB Medical Advisory Council. Calapis highlights several advancements in TB control, but also underscores the need for more local investment to ensure the sustainability of these efforts.
One significant development is the integration of artificial intelligence (AI) into TB detection. AI-equipped chest x-ray vans can quickly identify potential TB cases, reducing diagnostic delays. This innovation is a game-changer, especially in areas where access to radiologists is limited. Calapis notes that this technology can provide immediate results, allowing for prompt sputum tests to confirm TB infections.
The country has also made strides in treating drug-resistant TB, a more challenging form of the disease. New treatment regimens have shortened the duration of therapy from 20 months to just six months. This reduction in treatment time is a crucial step towards better patient outcomes and management.
Furthermore, Calapis mentions the training of primary healthcare workers and community-based partners. This initiative aims to provide comprehensive care for TB patients at the point of entry, ensuring that patients receive the necessary treatment without needing to reach sub-specialists. This approach can improve access to care and reduce the burden on specialized healthcare facilities.
However, despite these achievements, the Philippines still faces a heavy TB burden. In 2025, the country was ranked as the third-most affected by TB globally, accounting for 6.8% of all global cases. Calapis attributes this to increased TB notifications due to extensive testing. She emphasizes the importance of local investment to sustain these efforts, as a reduction in support could lead to delayed diagnoses, incomplete treatments, and a lack of essential drugs.
One area for improvement, according to Calapis, is multi-disease testing for TB patients. This method involves testing a patient's specimen for multiple illnesses, potentially reducing costs for both patients and medical laboratories. However, it requires a robust specimen transportation system, which may be a challenge to implement.
Awareness remains another critical aspect. Despite the National TB Control Program's establishment in 1978, there is still a gap in public awareness. Many patients seek treatment at late stages of the disease, mistaking TB symptoms for a common cough. Calapis suggests that improving information dissemination and awareness is essential to encourage early detection and treatment.
In conclusion, while the Philippines has made significant progress in TB control, there are still challenges to overcome. Local investment, multi-disease testing, and awareness campaigns are crucial components to ensure the sustainability and effectiveness of TB control programs. Calapis' insights highlight the need for a comprehensive approach to tackle this global health issue.
